CELC
Celcuity LLC
NASDAQ: CELC · HEALTHCARE · BIOTECHNOLOGY
$121.35
+1.97% today
Updated 2026-04-30
Market cap
$5.80B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.79
Dividend yield
—
52W range
$10 – $129
Volume
0.7M
Celcuity LLC (CELC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-163.80%
ROA
-30.20%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-2.26M | — | — | — |
| 2016 | $0.00 | $-3.31M | — | — | — |
| 2017 | $0.00 | $-6.25M | — | — | — |
| 2018 | $0.00 | $-7.48M | — | — | — |
| 2019 | $0.00 | $-7.36M | — | — | — |
| 2020 | $0.00 | $-9.47M | — | — | — |
| 2021 | $0.00 | $-29.61M | — | — | — |
| 2022 | $0.00 | $-40.37M | — | — | — |
| 2023 | $0.00 | $-63.78M | — | — | — |
| 2024 | $0.00 | $-111.78M | — | — | — |
| 2025 | $154000.00 | $-177.04M | -108.44% | -111,812.99% | -114,962.34% |